Cathelicidins and innate defense against invasive bacterial infection.
about
Cholinergic regulation of keratinocyte innate immunity and permeability barrier integrity: new perspectives in epidermal immunity and diseaseModulation of neutrophil NETosis: interplay between infectious agents and underlying host physiology.Antimicrobial peptides in reptilesCationic host defense peptides; novel antimicrobial therapeutics against Category A pathogens and emerging infections.Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin.Vitamin D and the intracrinology of innate immunity.Antimicrobial anxiety: the impact of stress on antimicrobial immunityIL-17A and IFN-γ synergistically induce RNase 7 expression via STAT3 in primary keratinocytesInterplay between bladder microbiota and urinary antimicrobial peptides: mechanisms for human urinary tract infection risk and symptom severity.Expression of cathelicidin LL-37 during Mycobacterium tuberculosis infection in human alveolar macrophages, monocytes, neutrophils, and epithelial cells.Interaction of antimicrobial peptide temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria.Serum 1,25-dihydroxyvitamin D: an outcome prognosticator in human sepsisMolecular analysis of non-specific protection against murine malaria induced by BCG vaccination.Roles of the host oxidative immune response and bacterial antioxidant rubrerythrin during Porphyromonas gingivalis infection.The effect of curcumin and cotrimoxazole in salmonella typhimurium infection in vivoPenicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides.Effects of the antimicrobial peptide cathelicidin (LL-37) on immortalized gingival fibroblasts infected with Porphyromonas gingivalis and irradiated with 625-nm LED light.Defensins and other antimicrobial peptides at the ocular surfaceMethicillin-resistant Staphylococcus aureus bacterial nitric-oxide synthase affects antibiotic sensitivity and skin abscess development.Cathelicidin LL-37 in severe Streptococcus pyogenes soft tissue infections in humansCathelicidins and functional analogues as antisepsis molecules.Human antimicrobial proteins effectors of innate immunity.Signatures of natural selection are not uniform across genes of innate immune system, but purifying selection is the dominant signature.Antimicrobial peptides, skin infections, and atopic dermatitisStaphylococcus aureus evasion of innate antimicrobial defense.Genetic variation and haplotype structures of innate immunity genes in eastern India.The antibacterial peptide ABP-CM4: the current state of its production and applications.Innate immunity and the role of the antimicrobial peptide cathelicidin in inflammatory skin disease.Roles of cathelicidins in inflammation and bone loss.Epithelial antimicrobial peptides: guardian of the oral cavity.Entamoeba histolytica induces intestinal cathelicidins but is resistant to cathelicidin-mediated killing.The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses.Expression and secretion of cathelicidin LL-37 in human epithelial cells after infection by Mycobacterium bovis Bacillus Calmette-GuérinExpression and modulation of LL-37 in normal human keratinocytes, HaCaT cells, and inflammatory skin diseases.Antimicrobial activity of four cationic peptides immobilised to poly-hydroxyethylmethacrylate.Mammalian antimicrobial peptide influences control of cutaneous Leishmania infection.HIF-1alpha expression regulates the bactericidal capacity of phagocytes.
P2860
Q26998399-86677405-137D-4A9B-A2CF-F0D49C2C1336Q27693200-9AC0D512-E70C-4923-A359-3E634F99AB91Q28656399-A64735FE-EECD-4AF4-AA8D-F8BBD2775564Q30151971-3AEA7B98-B612-4EE0-B4F0-254461F1E3CAQ33336048-8B19711D-05EE-4C2D-BEF2-383E7240ACABQ33787809-3FBCCC6C-69CD-40D7-B5DE-6452433E02C9Q34015443-38A10720-33FF-4508-964B-77E24979DDADQ34651452-559AED84-D800-4155-848B-6765B970B39CQ34655040-6F6CB55C-7CA6-4D68-AF75-DA14784A2029Q34655555-6A62D7A7-C825-4B70-9B67-B3A84EFD6609Q34721515-E11A4355-1326-4313-8C83-7F2CC9D60C1FQ34760458-CC9C53A8-9B81-4C90-9B17-DE237CDAE8CEQ34825271-7F2D4671-D763-41BB-9D53-DA16EDF267C9Q34862986-82C10233-D487-4B48-B46D-4765605308EBQ35001003-DCC6A6A6-171B-4870-928F-158F251499B1Q35217549-FB1C3D3D-123F-40DB-BD63-726114092D65Q35534698-F3F6F587-8929-445E-997C-1159BBAFA355Q35594084-AB5C1C0F-2127-4175-9245-DDA07E5D69E4Q36647337-B5D483CA-BBAD-420C-B615-ADACA01183E3Q36804326-81E3EF81-C88C-4492-9C4D-61A4D074C339Q36897327-B2736841-28C8-4683-A736-880851DDFBFDQ37053332-BE930E49-96D0-43B0-8140-DC3622A5F4F8Q37182685-50B288CA-32E9-49DE-AEC9-298C866D8B89Q37213664-44C9E3F9-C2BD-4DF5-ACF4-1C2D18F17E44Q37225675-B84D4558-4F42-4CF8-9AD3-3915497229B0Q37389087-FF663302-F0E9-4AD5-B0D6-9E7A4739E5F2Q37909101-3F87BA05-BF77-41AF-85B8-5B99027159F7Q38184541-3042246C-DC29-4853-98CF-0F8A3534DCC9Q38232252-87C278FC-3ADE-42E1-BE54-26B355F988C9Q38272974-3520BC1E-0118-41D3-9E0C-992358AC40E5Q39443130-0B00574A-42E6-4E62-B6FE-82E14B50C4E5Q39900739-DF128645-F636-42C1-BF33-6877214A3446Q39968181-42840347-9240-4484-9CE1-3EAA60E3C2A7Q40385253-E149E157-DAD2-4142-BE02-52E1EACE11F0Q40770547-E23E8D8B-F3F9-4E78-B387-A4D4B97720D7Q42177826-E3374C6B-A5B7-4DC8-A1EF-A7190F292D2DQ42876119-00308A98-CA20-461D-AD69-9BE3B35898E2
P2860
Cathelicidins and innate defense against invasive bacterial infection.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Cathelicidins and innate defense against invasive bacterial infection.
@ast
Cathelicidins and innate defense against invasive bacterial infection.
@en
type
label
Cathelicidins and innate defense against invasive bacterial infection.
@ast
Cathelicidins and innate defense against invasive bacterial infection.
@en
prefLabel
Cathelicidins and innate defense against invasive bacterial infection.
@ast
Cathelicidins and innate defense against invasive bacterial infection.
@en
P2860
P1476
Cathelicidins and innate defense against invasive bacterial infection.
@en
P2093
Richard L Gallo
P2860
P304
P356
10.1080/00365540310015629
P50
P577
2003-01-01T00:00:00Z